Your English writing platform
Discover LudwigSimilar(60)
This step of proof-of-principle (PoP) or proof-of-concept (PoC) often links between Phase-I and dose ranging Phase-II studies.
These have been used to study problems ranging from phase behavior to membrane fusion.
They should be undertaken after proof of efficacy has been obtained using a single short presurgical AED withdrawal study backed up by a substantive dose-ranging phase III efficacy trial.
The aim of dose-ranging phase I (resp. phase II) clinical trials is to rapidly identify the maximum tolerated dose (MTD) (resp., minimal effective dose (MED)) of a new drug or combination.
Phase 1: safety, tolerability Phase 2: Proof of concept, dose range Phase 3: drug approval, efficacy.
But this information pseudo range, phase data, receiver time, and so on varies from manufacturer to manufacturer.
In this fd range, phase velocity increases under tensile loading and group velocity decreases.
After translation motion compensation including range cell alignment and phase autofocus, we proposed the techniques focus on general cross range phase parameter estimation.
We have focused on oscillation frequency, tuning range, phase noise, output power optimization and buffer stage specifications.
By theoretical analyses and simulated verifications, a frequency-doubling microwave signal ranging from 22 to 40 GHz with full range phase shift is achieved.
First, we estimate the computational burden of the proposed bistatic chirp-scaling algorithm with N rg range samples and N az azimuth samples, which consists of the following main parts as discussed in the previous section: FFTs in azimuth, multiplication by the chirp-scaling function, FFTs in range, phase multiplication, IFFTs in range, phase multiplication in azimuth, and IFFTs in azimuth.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com